Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
종목 코드 PACB
회사 이름Pacific Biosciences of California Inc
상장일Oct 27, 2010
CEOMr. Christian O. Henry
직원 수575
유형Ordinary Share
회계 연도 종료Oct 27
주소1305 O'brien Drive
도시MENLO PARK
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호94025
전화16505218000
웹사이트https://www.pacb.com/
종목 코드 PACB
상장일Oct 27, 2010
CEOMr. Christian O. Henry
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음